DOCSLIB.ORG

Dame Bridget Ogilvie, Chair Professor Nancy Ip

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dame Bridget Ogilvie, Chair Professor Nancy Ip STRATEGIC REPORT on HFSPO by the INDEPENDENT SCIENTIFIC REVIEW COMMITTEE (ISRC) September 29, 2018 The views expressed herein are those of the authors and do not necessarily reflect the position of their employers or affiliated organizations. Short Bio Sketches of the ISRC members Dame Bridget Ogilvie, Chair Former Director of the Wellcome Trust Chair of International Advisory Board, ARC Centre of Excellence for Electromaterials Science, University of Wollongong Deputy Chair, Sense About Science Council Member, St George's House Trust, Windsor Castle Selected accomplishments: Fellow of the Royal Society Dame of the British Empire Fellow of Academy of Medical Sciences Fellow of the Australian Academy of Science Companion of the Order of Australia Establishment of Wellcome Trust Sanger Institute Professor Nancy Ip Vice-President for Research and Graduate Studies, Morningside Professor of Life Science, and the Director of the State Key Laboratory of Molecular Neuroscience at The Hong Kong University of Science and Technology (HKUST). Selected accomplishments: Member of the Chinese Academy of Sciences Member of the US National Academy of Sciences Member of the World Academy of Sciences, Member of the American Academy of Arts and Sciences. Councillor for the Society for Neuroscience, Member of the World Economic Forum Global Agenda Council National Natural Science Awards L’OREAL-UNESCO for Women in Science Award 10 Science Stars of China by Nature. 1 Dr. Jill Heemskerk Acting Director, National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health. Deputy Director, NIBIB, NIH Selected accomplishments: Former Director for Research Administration, NIBIB, NIH Former Deputy Director for the Division of Adult Translational Research, National Institute of Mental Health, NIH Former Acting Director of the Office of Translational Research at the National Institute of Neurological Disorders and Stroke, NIH. Former Advisory Board member of the ALS Association, the Spinal Muscular Atrophy Foundation, and the Huntington’s Disease Society of America. Professor Mats Ulfendahl Professor, Director of Research, Regional Council of Östergötland Chair, Swedish Society for Medical Research Chair, Delegation for Research of the Swedish Society of Medicine Selected accomplishments Former Secretary-General for medicine and health, Swedish Research Council Former Director of the Center for Hearing and Communication Research, Karolinska Institutet. Chair of international expert panel for interim evaluation of EDCTP2 (European Commission) Former Chair of the management board of Joint Programming Initiative on Antimicrobial Resistance Honorary Doctor (Dr h.c.) of Odontology, Malmö University The Petrus and Augusta Hedlund 40-year anniversary award HFSP involvement Program Grant 2003 2 Eric Westhof Emeritus Professor, Université de Strasbourg (France). Institut de biologie moléculaire et cellulaire du CNRS, Strasbourg, France. Selected accomplishments: Former Director of the Unit and the Institute (2005-2016). Former Vice-President for Research and Doctoral Studies at the University of Strasbourg (2007-2012). Member of European Molecular Biology Organization (EMBO) (1998), Deutsche Akademie der Naturforscher (LEOPOLDINA) (2000), the French Academy of Sciences (2011). Lifetime Achievement Award, International RNA Society, Kyoto (2016). HFSP involvement: HFSP Research Grants 1997 and 2005. 3 EXECUTIVE SUMMARY Main conclusions of the ISRC HFSP grants and fellowships are highly recognized and a real mark of distinction. HFSPO is successful in its strategy to enhance and synergize national science funding programs. HFSPO is international at every level. The current policy of funding curiosity-driven, daring, interdisciplinary and international research, without any priority given to a scientific topic or area, has been particularly successful. Main results of the Science Metrix Analysis . All the indicators point to the high impact level of the scientific outcomes. Bibliometric comparisons with other national or international funders, all much larger than HFSP, are stunningly convincing that the scientific returns on investment are significantly above world average. The analysis demonstrates the very high quality of the review and selection processes. The post-doctoral fellowships are an undoubted “success story”. The analysis demonstrates that HFSP Research Grants are unique in combining impact, multidisciplinary collaboration and interdisciplinary research at the same time. The funding amount and duration of the awards are no longer competitive relative to other funding programs. Major recommendations of the ISRC Restore attractiveness of the awards by increasing their amount and duration. This will require an increase in the budget. Focus on Grants and Fellowships. Encourage repatriation of HFSP fellows. The Career Development Awards should cease and the salient features as well as the funds should be made available as an option for the long-term and cross-disciplinary fellows from the start of these awards. Supporting comments Continue to build up the Alumni Network of HFSP worldwide to promote international understanding, scientific integration, and increase connectivity. Continue to exploit Awardees Meetings to promote internationality. Invite board members and alumni. Continue to make efforts to attract other countries that are key to the global scientific endeavor to join HFSPO. HFSP grants and fellowships are highly recognized, very competitive and a real mark of 4 distinction. The main strategic objective of HFSP is to enhance and synergize the national science Preamble This strategic report is intended for the Board of HFSPO in order to prepare the Intergovernmental Conference in 2019, which coincides with the 30th anniversary of the Program. The Secretary-General, Warwick Anderson, originated the idea and the organization of the ISRC. The Board of Trustees validated the process on 25 October 2016. Both the members of the ISRC and the reviewing organization were chosen among a list furnished by the Board of Trustees and the final choice and terms of reference approved by the Board by email on 13 April 2017. The Committee members met several times in person and during teleconferences (see The installation of the Independent Scientific Review Committee in the Appendix). At the outset the committee members would like to acknowledge the imaginative and visionary perspective of Japan about three decades ago when Hon. Yasuhiro Nakasone proposed HFSPO at the 1987 G7 summit in Venice. The idea of former Japanese Prime Minister Yasuhiro Nakasone was to establish a funding organization for basic research in the life sciences. The following words pronounced by Hon. Yasuhiro Nakasone in 1987 were discerning and far-sighted: “HFSP was meant to be a 21st century, long-term global research program fostering international cooperation for the benefit of mankind, under which courageous researchers from throughout the world and the spirit of challenge would form teams to analyze and discover various complex mechanisms of living organisms”.1 This Report is not meant primarily as an evaluation report, but instead aims at presenting a strategic analysis setting a vision that should go beyond maturation following three decades of very successful and pioneering activities. In support of this effort, an independent analysis was commissioned from Science Metrix Inc.2 by the Secretary-General of HFSPO upon the advice of the ISRC. The analysis is quantitative and based on various criteria and data sets including interviews, case studies, surveys and extensive bibliometrics. The Independent Scientific Review Committee validated the methodology and the indicators used after several exchanges with Science Metrix agents. The staff at HFSPO participated in those exchanges, prepared and sent the necessary datasets and files from the HFSPO archives. We aim to answer the following questions: What is truly unique and distinctive about HFSP funding? How successful and impactful is the HFSP funding? What aspects of the funding schemes should be maintained, improved, amended or discontinued? In this Final Report, the evaluation performed by Science Metrix provides the observational data on which the Independent Scientific Review Committee (ISRC) elaborated and built a forward- looking strategic vision with clear recommendations to the Board. In the present Report, results from the Science Metrix analysis will not be systematically considered or discussed, but references to it will be given when judged appropriate. With a funding budget of HFSPO around $55 million/year, it is obvious that scientists worldwide depend essentially on national funding throughout their careers. HFSPO incorporates, therefore, as a main axiom that its central objective is to enhance and synergise the science promotion and funding strategies of the national funders. Consequently, we stress HFSP’s added value compared to what 1 From HFSP Strategic outlook Final.pdf 2 See Science-Metrix Inc 5 can be done at a national level. A second foundation is that the core element of the uniqueness of HFSPO is its in-built international character at every level, starting with its funders and members, to the peer review committee members, the awardees, and the scientific and managing staff of the organization. We will use this common thread throughout the document. The Independent Scientific Review Committee (ISRC) is indebted to HFSPO staff for their very constructive help
Load more

Recommended publications
  • Female Fellows of the Royal Society
    Female Fellows of the Royal Society Professor Jan Anderson FRS [1996] Professor Ruth Lynden-Bell FRS [2006] Professor Judith Armitage FRS [2013] Dr Mary Lyon FRS [1973] Professor Frances Ashcroft FMedSci FRS [1999] Professor Georgina Mace CBE FRS [2002] Professor Gillian Bates FMedSci FRS [2007] Professor Trudy Mackay FRS [2006] Professor Jean Beggs CBE FRS [1998] Professor Enid MacRobbie FRS [1991] Dame Jocelyn Bell Burnell DBE FRS [2003] Dr Philippa Marrack FMedSci FRS [1997] Dame Valerie Beral DBE FMedSci FRS [2006] Professor Dusa McDuff FRS [1994] Dr Mariann Bienz FMedSci FRS [2003] Professor Angela McLean FRS [2009] Professor Elizabeth Blackburn AC FRS [1992] Professor Anne Mills FMedSci FRS [2013] Professor Andrea Brand FMedSci FRS [2010] Professor Brenda Milner CC FRS [1979] Professor Eleanor Burbidge FRS [1964] Dr Anne O'Garra FMedSci FRS [2008] Professor Eleanor Campbell FRS [2010] Dame Bridget Ogilvie AC DBE FMedSci FRS [2003] Professor Doreen Cantrell FMedSci FRS [2011] Baroness Onora O'Neill * CBE FBA FMedSci FRS [2007] Professor Lorna Casselton CBE FRS [1999] Dame Linda Partridge DBE FMedSci FRS [1996] Professor Deborah Charlesworth FRS [2005] Dr Barbara Pearse FRS [1988] Professor Jennifer Clack FRS [2009] Professor Fiona Powrie FRS [2011] Professor Nicola Clayton FRS [2010] Professor Susan Rees FRS [2002] Professor Suzanne Cory AC FRS [1992] Professor Daniela Rhodes FRS [2007] Dame Kay Davies DBE FMedSci FRS [2003] Professor Elizabeth Robertson FRS [2003] Professor Caroline Dean OBE FRS [2004] Dame Carol Robinson DBE FMedSci
    [Show full text]
  • Clinical Molecular Genetics in the Uk C.1975–C.2000
    CLINICAL MOLECULAR GENETICS IN THE UK c.1975–c.2000 The transcript of a Witness Seminar held by the History of Modern Biomedicine Research Group, Queen Mary, University of London, on 5 February 2013 Edited by E M Jones and E M Tansey Volume 48 2014 ©The Trustee of the Wellcome Trust, London, 2014 First published by Queen Mary, University of London, 2014 The History of Modern Biomedicine Research Group is funded by the Wellcome Trust, which is a registered charity, no. 210183. ISBN 978 0 90223 888 6 All volumes are freely available online at www.history.qmul.ac.uk/research/modbiomed/ wellcome_witnesses/ Please cite as: Jones E M, Tansey E M. (eds) (2014) Clinical Molecular Genetics in the UK c.1975–c.2000. Wellcome Witnesses to Contemporary Medicine, vol. 48. London: Queen Mary, University of London. CONTENTS What is a Witness Seminar? v Acknowledgements E M Tansey and E M Jones vii Illustrations and credits ix Abbreviations xi Ancillary guides xiii Introduction Professor Bob Williamson xv Transcript Edited by E M Jones and E M Tansey 1 Appendix 1 Photograph, with key, of delegates attending The Molecular Biology of Thalassaemia conference in Kolimbari, Crete, 1978 88 Appendix 2 Extracts from the University of Leiden postgraduate course Restriction Fragment Length Polymorphisms and Human Genetics, 1982 91 Appendix 3 Archival material of the Clinical Molecular Genetics Society 95 Biographical notes 101 References 113 Index 131 Witness Seminars: Meetings and Publications 143 WHAT IS A WITNESS SEMINAR? The Witness Seminar is a specialized form of oral history, where several individuals associated with a particular set of circumstances or events are invited to meet together to discuss, debate, and agree or disagree about their memories.
    [Show full text]
  • Part I Officers in Institutions Placed Under the Supervision of the General Board
    2 OFFICERS NUMBER–MICHAELMAS TERM 2009 [SPECIAL NO.7 PART I Chancellor: H.R.H. The Prince PHILIP, Duke of Edinburgh, T Vice-Chancellor: 2003, Prof. ALISON FETTES RICHARD, N, 2010 Deputy Vice-Chancellors for 2009–2010: Dame SANDRA DAWSON, SID,ATHENE DONALD, R,GORDON JOHNSON, W,STUART LAING, CC,DAVID DUNCAN ROBINSON, M,JEREMY KEITH MORRIS SANDERS, SE, SARAH LAETITIA SQUIRE, HH, the Pro-Vice-Chancellors Pro-Vice-Chancellors: 2004, ANDREW DAVID CLIFF, CHR, 31 Dec. 2009 2004, IAN MALCOLM LESLIE, CHR, 31 Dec. 2009 2008, JOHN MARTIN RALLISON, T, 30 Sept. 2011 2004, KATHARINE BRIDGET PRETTY, HO, 31 Dec. 2009 2009, STEPHEN JOHN YOUNG, EM, 31 July 2012 High Steward: 2001, Dame BRIDGET OGILVIE, G Deputy High Steward: 2009, ANNE MARY LONSDALE, NH Commissary: 2002, The Rt Hon. Lord MACKAY OF CLASHFERN, T Proctors for 2009–2010: JEREMY LLOYD CADDICK, EM LINDSAY ANNE YATES, JN Deputy Proctors for MARGARET ANN GUITE, G 2009–2010: PAUL DUNCAN BEATTIE, CC Orator: 2008, RUPERT THOMPSON, SE Registrary: 2007, JONATHAN WILLIAM NICHOLLS, EM Librarian: 2009, ANNE JARVIS, W Acting Deputy Librarian: 2009, SUSANNE MEHRER Director of the Fitzwilliam Museum and Marlay Curator: 2008, TIMOTHY FAULKNER POTTS, CL Director of Development and Alumni Relations: 2002, PETER LAWSON AGAR, SE Esquire Bedells: 2003, NICOLA HARDY, JE 2009, ROGER DERRICK GREEVES, CL University Advocate: 2004, PHILIPPA JANE ROGERSON, CAI, 2010 Deputy University Advocates: 2007, ROSAMUND ELLEN THORNTON, EM, 2010 2006, CHRISTOPHER FORBES FORSYTH, R, 2010 OFFICERS IN INSTITUTIONS PLACED UNDER THE SUPERVISION OF THE GENERAL BOARD PROFESSORS Accounting 2003 GEOFFREY MEEKS, DAR Active Tectonics 2002 JAMES ANTHONY JACKSON, Q Aeronautical Engineering, Francis Mond 1996 WILLIAM NICHOLAS DAWES, CHU Aerothermal Technology 2000 HOWARD PETER HODSON, G Algebra 2003 JAN SAXL, CAI Algebraic Geometry (2000) 2000 NICHOLAS IAN SHEPHERD-BARRON, T Algebraic Geometry (2001) 2001 PELHAM MARK HEDLEY WILSON, T American History, Paul Mellon 1992 ANTHONY JOHN BADGER, CL American History and Institutions, Pitt 2009 NANCY A.
    [Show full text]
  • HUMAN GENE MAPPING WORKSHOPS C.1973–C.1991
    HUMAN GENE MAPPING WORKSHOPS c.1973–c.1991 The transcript of a Witness Seminar held by the History of Modern Biomedicine Research Group, Queen Mary University of London, on 25 March 2014 Edited by E M Jones and E M Tansey Volume 54 2015 ©The Trustee of the Wellcome Trust, London, 2015 First published by Queen Mary University of London, 2015 The History of Modern Biomedicine Research Group is funded by the Wellcome Trust, which is a registered charity, no. 210183. ISBN 978 1 91019 5031 All volumes are freely available online at www.histmodbiomed.org Please cite as: Jones E M, Tansey E M. (eds) (2015) Human Gene Mapping Workshops c.1973–c.1991. Wellcome Witnesses to Contemporary Medicine, vol. 54. London: Queen Mary University of London. CONTENTS What is a Witness Seminar? v Acknowledgements E M Tansey and E M Jones vii Illustrations and credits ix Abbreviations and ancillary guides xi Introduction Professor Peter Goodfellow xiii Transcript Edited by E M Jones and E M Tansey 1 Appendix 1 Photographs of participants at HGM1, Yale; ‘New Haven Conference 1973: First International Workshop on Human Gene Mapping’ 90 Appendix 2 Photograph of (EMBO) workshop on ‘Cell Hybridization and Somatic Cell Genetics’, 1973 96 Biographical notes 99 References 109 Index 129 Witness Seminars: Meetings and publications 141 WHAT IS A WITNESS SEMINAR? The Witness Seminar is a specialized form of oral history, where several individuals associated with a particular set of circumstances or events are invited to meet together to discuss, debate, and agree or disagree about their memories. The meeting is recorded, transcribed, and edited for publication.
    [Show full text]
  • Michaelmas Term 2002 Special No.6 Part I
    2 OFFICERS NUMBER–MICHAELMAS TERM 2002 SPECIAL NO.6 PART I Chancellor: H.R.H. The Prince PHILIP, Duke of Edinburgh, T Vice-Chancellor: 1996, Prof. Sir Alec BROERS, CHU, 2003 Deputy Vice-Chancellors: for 2002–2003: A. M. LONSDALE, NH,M.J.GRANT, CL,O.S.O’NEILL, N, Sir ROGER TOMKYS, PEM,D.E.NEWLAND, SE,S.G.FLEET, DOW,G.JOHNSON, W Pro-Vice-Chancellors: 1998, A. M. LONSDALE, NH, 30 June 2004 2001, M. GRANT, CL, 31 Dec. 2004 High Steward: 2001, Dame BRIDGET OGILVIE, G Deputy High Steward: 1983, The Rt Hon. Lord RICHARDSON, CAI Commissary: 2002, Lord MACKAY, T Proctors for 2002–2003: J. D. M ACDONALD, CAI Deputy: D. J. CHIVERS, SE T. N. M ILNER, PET Deputy: V.E. IZZET, CHR Orator: 1993, A. J. BOWEN, JE Registrary: 1997, T. J. MEAD, W Deputy Registrary: 1993, N. J. B. A. BRANSON, DAR Secretary General of the Faculties: 1992, D. A. LIVESEY, EM Treasurer: 1993, J. M. WOMACK, TH Librarian: 1994, P.K. FOX, SE Deputy Librarians: 1996, D. J. HALL, W 2000, A. MURRAY, W Director of the Fitzwilliam Museum and Marlay Curator: 1995, D. D. ROBINSON, M Development Director: 2002, P.AGAR, SE Esquire Bedells: 1996, J. P.EMMINES, PET 1997, J. H. WILLIAMS, HH University Advocate: 1999, N. M. PADFIELD, F, 2003 Deputy University Advocate: 1999, P.J. ROGERSON, CAI, 2003 OFFICERS IN INSTITUTIONS PLACED UNDER THE SUPERVISION OF THE GENERAL BOARD PROFESSORS Accounting Vacant Aeronautical Engineering, Francis Mond 1996 W.N. DAWES, CHU Aerothermal Technology 2000 H. P.HODSON, G African Archaeology 2001 D.
    [Show full text]
  • 80 Stephen Paget Memorial Lecture and Openness Awards Ceremony 5
    80th Stephen Paget Memorial Lecture and Openness Awards Ceremony 5th December 2016 Royal College of Physicians, London #ConcordatOpenness Programme 18:00 Arrival and Refreshments 18:30 Welcome Address 18:40 Openness Awards Internal or sector engagement activity Public engagement activity Media engagement or media stories Website or use of new media Individual award 19:00 80th Paget Lecture by Professor Sir Mark Walport Animal Research – Then and Now 20:00 Drinks Reception 21:30 End The Stephen Paget Memorial Lecture The Stephen Paget Memorial Lecture is a scientific lecture to commemorate the life of Dr Stephen Paget. Stephen Paget (1855 – 1926) was the founder of the Research Defence Society, a forerunner of Understanding Animal Research. He believed passionately that better science and understanding of physiology would lead to better medical treatments. After his death in 1926, he was greatly missed by his medical colleagues and the scientific community. The first Stephen Paget memorial lecture was given in 1927 to commemorate his life and allow leading bio-medical scientists of the day to talk about their research. The Openness Awards The Concordat on Openness launched in May 2014 and has to date brought together 109 organisations in a pledge to be more open and transparent about the use of animals in research. This year the Openness Awards celebrate five recipients that have met the Concordat commitments and encouraged the widespread sharing of best practice. Professor Sir Mark Walport, FRS, FMedSci Sir Mark is the Chief Scientific Adviser to HM Government and Head of the Government Office for Science. Previously, Sir Mark was Director of the Wellcome Trust.
    [Show full text]
  • Dame Bridget Ogilvie Hon Dsc
    Dame Bridget Ogilvie Hon DSc Oration by Professor Richard Lilford Warwick Medical School Dame Bridget Ogilvie Hon DSc Professor Dame Bridget Ogilvie is, as her titles suggest, a person of But it was time for Bridget to move on. It is easy to attribute exceptional achievement. scientific discovery to us scientists. But modern scientists are dependent on how science is funded and governed. So in 1981 Bridget grew up on an Australian sheep farm and this engendered, Bridget decided to stretch her wings, and accept a senior science in her receptive mind, an interest in the animals she saw around policy role at the Wellcome Trust, rising to become its Director in her, in the diseases that afflict the animals and, in due course, in 1991. The Wellcome Trust is the world’s second largest medical the power of science to transform animal husbandry. Bridget also charity, after the Bill and Melinda Gates Foundation, and currently had educational advantages – her father was an alumnus of Oxford invests over £1 billion in research each year. Bridget established University (no University of Warwick in those days) and she had the the Sanger Centre in Cambridge, the first centre in the world to benefit of an exceptional teacher at her local village school – one sequence the human genome. AB Clark. A fascination with life in all its forms, and her passion for education, run like a thread through her career. She also increased the rate at which scientific discoveries are translated into practical improvements by sponsoring Clinical Bridget started higher education at Queensland University, but her Tropical Medicine Centres and our previous Dean of Medicine, ‘pure science’ course failed to excite her imagination so, on learning Professor Peter Winstanley, was director of such a centre.
    [Show full text]
  • 2011 to 2018 Lister Annual Report and Accounts
    The L ister Institute of Preventive Medicine PO Box 1083, Bushey, Hertfordshire WD23 9AG 3 ANNUAL REPORT AND FINANCIAL STATEMENTS for the year ended 3 1 December 2011 O o The Lister Institute of Preventive Medicine is a company limited by guarantee (England 34479) and a registered charity (206271) The Institute was founded in 1891 and for the next 80 years played a vital role in the development of the laboratory aspects of preventive medicine as an independent research institute in the UK. Financial pressures in the 1970s led to the closure of the research and production facilities and the conversion of the Lister Institute into a highly successful trust awarding prestigious Research Fellowships from 1982 which in 2003, again because of financial pressures, were revised to become Prize Fellowships. The cover portrait of Lord Lister reproduced by courtesy of the Royal Veterinary College THE LISTER INSTITUTE OF PREVENTIVE MEDICINE LEGAL AND ADMINISTRATIVE INFORMATION for the year ended 3 1 December 2 0 1 I THE GOVERNING BODY Dame Bridget M Ogilvie, DBE, AC, ScD, FMedSci, FRS, Chairman (Retired 9 September 2011) Professor Sir Alex Markham, DSc, FRCP, FRCPath, FMedSci, Chairman (From 9 September 2011) Mr Michael French, BSc(Eng), FCA, Hon Treasurer Professor Janet Darbyshire, CBE, FRCP, FFPH, FMedSci (Appointed I December 2011) Professor Dame Kay Davies, CBE, DBE, MA, DPhil, FMedSci, FRCP (Hon), FRCPath, FRS, (Appointed I December 2011) Hon Rory M B Guinness Professor Douglas Higgs, MB, BS, MRCP, MRCPath, DSc, FRCP, FRCPath (Appointed 9 September
    [Show full text]
  • TECHNOLOGY INNOVATION and SOCIETY Published Quarterly for the Information of Subscribers Summer 1995
    TECHNOLOGY INNOVATION AND SOCIETY Published Quarterly for the Information of Subscribers Summer 1995 FOUNDATION FOR SCIENCE AND TECHNOLOGY FOUNDATION FOR SCIENCE AND TECHNOLOGY Vice-Presidents The Lord Todd, O.M., P.P.R.S. The Earl of Shannon The Lord Flowers, F.R.S. Dr Richard J. Haas, C.B.E., LL.D., Hon. Sc.D. The Earl of Selborne, K.B.E., F.R.S. Sir Keith Thomas, P.B.A. The Lord Phillips of Ellesmere, K.B.E., F.R.S. Council Chairman: The Lord Butterworth, C.B.E., D.L. Deputy Chairman: Sir Richard Morris, C.B.E., F.Eng. The President of the Royal Society: Sir Michael Atiyah O.M., Hon. F. Eng., P.R.S. The President, The Royal Academy of Engineering: Sir William Barlow, F.Eng. Chairman, The Council of Science and Technology Institutes: Sir Colin Spedding, C.B.E. Chairman, The Biotechnology and Biological Sciences Research Council: Sir Alistair Grant Chairman, The Council for the Central Laboratory of the Research Council: Dr Paul Williams Chairman, The Economic and Social Research Council: Dr Bruce Smith, O.B.E. Chairman, The Engineering and Physical Sciences Research Council: Dr Alan Rudge, C.B.E., F.Eng., F.R.S. Chairman, The Medical Research Council: Sir David Plastow Chairman, The Natural Environment Research Council: Mr Robert Malpas, C.B.E., F.Eng. Chairman, The Particle Physics and Astronomy Research Council: Dr Peter Williams, C.B.E. Professor Chris Elliott (Honorary Secretary) Mr Roger Davidson (Honorary Treasurer) Sir Geoffrey Allen, F.Eng., F.R.S. Mr David Andrews, C.B.E.
    [Show full text]
  • SABRE Annual Report 2021
    Sandler Asthma Basic REsearch Center University of California, San Francisco Progress Report Year 22 July 2021 Figure Legend: Multi-detector computed tomography (MCTD) lung scan of a patient with poorly controlled asthma revealed occlusive mucus plugs of varying size and shape, which has been shown to correlate with worse lung function (technique developed and refined in the Fahy SABRE Center lab with UCSF Radiology). Therapeutic dissolution of plugs remains a priority in the Fahy lab. (Image contributed by Brendan Huang). TABLE OF CONTENTS Mission Statement 2 Summary of Accomplishments Overview 3 Executive Committee: Members and Functions 24 Scientific Advisory Board Susan Kaech, Ph.D. 26 Mitchell Kronenberg, Ph.D. 27 Ruslan Medzhitov, Ph.D. 28 SABRE Center Investigators Richard Locksley, M.D. 30 Christopher Allen, Ph.D. 32 K. Mark Ansel, Ph.D. 34 Esteban Burchard, M.D., M.P.H. 36 John Fahy, M.D., M.Sc. 38 Jeoung-Sook Shin, Ph.D. 40 Prescott Woodruff, M.D., M.P.H. 42 SABRE Associate Investigators Mallar Bhattacharya, M.D., MSc. 45 Erin Gordon, M.D. 47 Andrew Schroeder, M.P.H. 49 Aparna Sundaram, M.D. 50 Core Facilities Microscopy/BIDC 53 Asthma Related Research Projects Primero Birth Cohort 60 Single Cell Sequencing in Nasal Polyp Patients 70 Contributions to Relevant Scientific Activities 74 Publications Supported by the Sandler Asthma Basic Research Center 79 Looking to the future 136 Biographical Sketches 138 Mission Statement The Sandler Asthma Basic Research Center (SABRE Center) is an investigative unit dedicated to basic research discovery in asthma. Founded in 1999, the SABRE Center is nucleated by basic scientists supported by advanced technology cores and linked with the greater scientific community through Center Grants and Program Projects focused around asthma research.
    [Show full text]
  • Restoring Neurological Function: Putting the Neurosciences to Work in Neurorehabilitation
    Restoring Neurological Function: Putting the neurosciences to work in neurorehabilitation A report from the Academy of Medical Sciences March 2004 The independent Academy of Medical Sciences promotes advances in medical science and campaigns to ensure these are translated as quickly as possible into benefits for patients. The Academy’s Fellows are the United Kingdom’s leading medical scientists from hospitals, academia, industry and the public service. The aims of the Academy are: • to give national and international leadership in the medical sciences; • to promote the application of research to the practice of medicine and to the advancement of human health and welfare; • to promote the aims and ethos of medical sciences with particular emphasis on excellence in research and training; • to enhance public understanding of the medical sciences and their impact on society; • to assess and advise on issues of medical science of public concern. The Academy of Medical Sciences was established in 1998 following the recommendations of a working group chaired by Sir Michael Atiyah, Past President of the Royal Society. There is an elected Council of 22 Fellows that includes the five Officers of the Academy: President Sir Keith Peters, FRS, PMedSci Vice-President (Clinical) Lord Turnberg, FMedSci Vice-President (Non-clinical) Sir John Skehel, FRS, FMedSci Treasurer Sir Colin Dollery, FMedSci Registrar Professor Patrick Vallance, FMedSci The Academy’s Executive Director is Mrs Mary Manning. For more information about the work of the Academy please see
    [Show full text]
  • Final Zero Checked 2
    Brave New World of Zero Risk: Covert Strategy in British Science Policy Martin J Walker Slingshot Publications October 2005 Brave New World of Zero Risk: Covert Strategy in British Science Policy Martin J. Walker First published as an e-book, October 2005 © Slingshot Publications, October 2005 BM Box 8314, London WC1N 3XX, England Type set by Viviana D. Guinarte in Book Antiqua 11/12, Verdana Edited by Rose Shepherd Cover design by Andy Dark In this downloadable Pdf form this book is free and can be distributed by anyone as long as neither the contents or the cover are changed or altered in any way and that this condition is imposed upon anyone who further receives or distributes the book. In the event of anyone wanting to print hard copies for distribution, rather than personal use, they should consult the author through Slingshot Publications. Selected parts of the book can be reproduced in any form, except that of articles under the author’s name, for which he would in other circumstances receive payment; again these can be negotiated through Slingshot Publications. More information about this book can be obtained at: www.zero-risk.org For Marxists and neo liberals alike it is technological advance that fuels economic development, and economic forces that shape society. Politics and culture are secondary phenomena, sometimes capable of retarding human progress; but in the last analysis they cannot prevail against advancing technology and growing productivity. John Gray1 The Bush government is certainly not the first to abuse science, but they have raised the stakes and injected ideology like no previous administration.
    [Show full text]